Investor Fresenius SE & Co. KGaA
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Fresenius SE & Co. KGaA . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-03-10 13D/A FMS / Fresenius Medical Care AG - Depositary Receipt (Common Stock) 94,380,382 83,780,382
2025-03-06 13D/A FMS / Fresenius Medical Care AG - Depositary Receipt (Common Stock) 94,380,382 94,380,382
2023-12-07 13D/A FMS / Fresenius Medical Care AG - Depositary Receipt (Common Stock) 94,380,382 94,380,382
2023-03-22 13D/A FMS / Fresenius Medical Care AG - Depositary Receipt (Common Stock) 94,380,382
2019-01-08 13D/A AKRX / Akorn, Inc. 31,057,036 0
2017-05-04 13D AKRX / Akorn, Inc. 31,057,036
2012-03-01 13D/A 94,380,382
2012-02-16 13D/A 94,003,450